Niv Caviar, M.B.A
Chief Executive Officer Allergan, La Jolla Pharma, Suneva Medical, Affymetrix, Accenture, OC Life Science Partners
Mr. Caviar is a successful life science CEO, general manager with senior functional management experience in marketing, business development, strategic planning, engineering/manufacturing and finance (Nasdaq CFO). He successfully led, raised, and negotiated 35+ partner and financial transactions for $2.5 billion in total deal capital. Mr. Caviar was responsible for commercialization/marketing and product launch for five branded products (Rx small molecule, medical device, and biologic/injectables). He is an accomplished senior leader in pharmaceutical, biotech, and medical device industry segments, with management/leadership experience in both public and private (venture and private equity) companies. Niv Caviar is the former CEO of Suneva Medical, CFO/CBO of La Jolla Pharma (LJPC: Nasdaq), VP of Bus Development and VP, Head of Dermatolgoy Marketing at Allergan. Mr. Caviar holds an M.B.A from Harvard Business School.
Neville Alleyne, M.D.
Chief Medical Officer, Founder
Dr. Alleyne is a board certified orthopaedic surgeon and is the Director of the Orthopaedic Spine Center at Tri-City Medical Center in Oceanside, CA. Dr. Alleyne’s practice is focused on treating a broad spectrum of spinal disorders, and he has established a multi-disciplinary approach, using the latest minimally invasive techniques, to relieve pain and restore spinal stability and mobility. He founded and served as chief medical director for several start-up companies developing spinal barriers and instrumentation using pedicle screws, cervical plates and artificial discs, including ProSpine, NAS Medical, and Smartdisc Inc. Dr. Alleyne is the inventor on numerous published patent applications related to spinal methods and devices. He is a member of the American Academy of Orthopaedic Surgeons, the North American Spine Society, the California Orthopaedic Association and the J. Robert Gladden Orthopaedic Society. Dr. Alleyne performed his fellowship training in total joint arthroplasty and spine surgery at Harvard University-Massachusetts General Hospital and New England Baptist Hospital in Boston, MA. Dr. Alleyne completed his residency training at Yale New Haven Hospital in orthopaedics and general surgery in 1988. Dr. Alleyne received his medical degree from Mount Sinai School of Medicine in 1983 and was an undergraduate at Columbia University in New York, NY.
Nick J. Manesis, Ph.D.
Vice President, Research & Development
Mr. Manesis has over 27 years experience focused on R & D in the Life Sciences space. He has successfully driven both new product and existing product activities for high profile companies as Allergan, CooperVision, and Hewlett-Packard Company. He has provided leadership and management to large cross-functional teams across multiple projects both domestically and internationally. He is a strong advocate of customer-supplier principles, both internally and externally. Mr. Manesis holds a Ph.D. In Chemistry and has expertise in biomaterials within the medical device industry.
Vice President, Quality & Manufacturing
Mr. Packard has Medical Device Academy, Delcath, BSI, CAS, ConforMIS, Z-Medical, B.S., University of Connecticut 25 years of experience in the pharmaceutical, biotechnology and medical device industries. He is a graduate of UConn in Chemical Engineering. Mr. Packard was a senior manager at several medical device companies—including President/CEO of a laparoscopic imaging company. His Quality Management System expertise covers all aspects of developing, training, implementing and maintaining compliance with ISO 13485 and ISO 14971. From 2009-2012, he was a lead auditor and instructor for BSI. Mr. Packard’s specialty is CE marking of orthopedic devices and establishing quality systems for start-up companies.
Gloria C. Lin, Ph.D.
Executive Director of Operations
Dr. Lin has extensive experience in pharmaceutical and medical product development that encompasses clinical trial design and management, pre-clinical studies, and discovery. Dr. Lin held positions of increasing responsibilities at companies including Pfizer, Johnson & Johnson, and Allergan, as well as VC-backed portfolio companies. Dr. Lin received postdoctoral training at Harvard Medical School and Massachusetts General Hospital, and holds a Ph.D. in physical chemistry from UCLA.